Cesca Therapeutics Inc., of Rancho Cordova, Calif., entered subscription agreements with institutional investors for a registered direct offering of 600,000 common shares at $4.10 apiece, a 24 percent discount to the closing price of $5.42 for the company's shares (NASDAQ:KOOL) on Aug. 3.